Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.

Authors
Publication date
1 January 2005
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    ORA - Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:90f43bae...
    Last time updated on 13/04/2022
    Supporting member

    Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:90f43bae...
    Last time updated on 30/09/2015